Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Key Stock Data
The current last sale of $8.155 is 89.21% Higher than the 52 week low.
|Intraday||Last 52 Weeks|
|High:||$ 8.26||$ 10.97|
|Low:||$ 8.105||$ 4.31|
ETFs with DEPO as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|0.78%||SPDR S&P Pharmaceuticals ETF (XPH)||+1.32 (3.01%)|
|*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green highlights the top performing ETF by % change in the past 100 days.|
Company Description (as filed with the SEC)
Depomed is a specialty pharmaceutical company focused on pain and other central nervous system (CNS) conditions. Our current specialty pharmaceutical business includes the following three products which we market in the United States (U.S.): · Gralise® (gabapentin), a oncedaily product for the management of postherpetic neuralgia (PHN), that we launched in October 2011. · CAMBIA® (diclofenac potassium for oral solution), a nonsteroidal antiinflammatory drug for the acute treatment of migraine attacks, that we acquired in December 2013. · Zipsor® (diclofenac potassium) liquid filled capsules, a nonsteroidal antiinflammatory drug for the treatment of mild to moderate acute pain, that we acquired in June 2012. ... More ...
Nasdaq Official Price
Jul. 20, 2018
Jul. 19, 2018